Health Care & Insurance

Disappointing quarter puts WellPoint brass on hot seatRestricted Content

February 11, 2012
Greg Andrews
Analysts say the company has struggled to generate the consistent earnings that rivals have, in part because of mispricing of its Medicare Advantage senior coverage.
More

BioCrossroads has stoked state's life sciences industry, but challenges remainRestricted Content

February 11, 2012
J.K. Wall
In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.
More

Lawsuit filed over denial of senior's home care

February 8, 2012
 IBJ Staff and Associated Press
A Carmel-based health insurer once owned by Conseco Inc. is being sued for refusing to pay claims for in-home care submitted by California senior citizens.
More

Health care VC hits new Indiana low in 2011

February 6, 2012
J.K. Wall
Indiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to  the state’s health care sector since BioEnterprises began tracking such deals in 2005.
More

Roche sales rise 4 percent in 2011

February 6, 2012
J.K. Wall
Roche Diagnostics Corp.’s North American business, which is headquartered in Indianapolis, posted a 4-percent boost in sales last year on the strength of its fluid analyzer business unit, even though its diabetes sales fell.
More

Drugmakers singing same song: 2012 will be tough

February 2, 2012
Associated Press
For drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview mirror any more.
More

Dow Agro posts record fourth quarter profit

February 2, 2012
 IBJ Staff and Associated Press
The Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the $72 million reported for the 2010 period.
More

Baldwin & Lyons ends tough year with quarterly profit

February 2, 2012
Indianapolis-based Baldwin & Lyons Inc. turned a profit in the fourth quarter, but it wasn’t enough to erase a dismal 2011 plagued by catastrophic losses.
More

Lilly eying deal with Turkish drug company

January 31, 2012
Bloomberg News
Eli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, sources say.
More

Community agrees to absorb Howard Regional

January 31, 2012
J.K. Wall
Kokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than four months after it broke off a merger deal with Indiana University Health.
More

Lilly's quarterly profit tumbles, but tops Wall Street estimates

January 31, 2012
J.K. Wall
Patent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected sales of other products.
More

Symmetry Ex-CEO Moore to return $450,000 in clawback suit

January 30, 2012
Bloomberg News
Symmetry Medical Inc.’s former CEO will return $450,000 in pay and stock proceeds to resolve U.S. Securities and Exchange Commission claims that he profited from accounting fraud by a United Kingdom unit.
More

Gallagher sees more broker mergers coming

January 30, 2012
J.K. Wall
The Carmel office of Arthur J. Gallagher & Co. just made its sixth acquisition in five years, and it expects looming changes to tax and health laws to produce even more chances to snap up benefits brokers this year.
More

Purdue hopes center simplifies commercialization

January 30, 2012
J.K. Wall
Purdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help developing their research into products and for outside investors to find out what research is taking place there.
More

Lilly's ex-partner wins FDA approval for diabetes drug

January 29, 2012
Bloomberg News
Amylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly and Co. co-developed the drug, but ended its partnership with Amylin last year.
More

UPDATE: WellPoint to boost primary-care pay

January 27, 2012
Associated Press
Health insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn't currently cover, changes that could give patients more quality time with their doctors.
More

Indiana House backs broader ban on synthetic drugs

January 26, 2012
Associated Press
The Indiana House has approved a bill that would broaden the state's ban on synthetic drugs to include compounds nicknamed "bath salts" and others that mimic marijuana.
More

Indiana Senate panel backs limits on abortion pill

January 25, 2012
Associated Press
The Senate health committee voted 5-4 in support of the bill that requires that a doctor examine a woman in person before giving her RU-486, provide written information about the physical risks of abortion and to schedule a follow-up ultrasound.
More

WellPoint shares sink after disappointing earnings report

January 25, 2012
 IBJ Staff and Associated Press
WellPoint Inc.'s stock price dropped almost 5 percent Wednesday after the insurer's fourth-quarter earnings failed to meet analyst expectations.
More

WellPoint earnings fall well short of analysts' expectations

January 25, 2012
J.K. Wall
The Indianapolis-based health insurer reported earnings of $335.3 million, or 96 cents per share, down 39 percent from the same quarter a year ago.
More

Eli Lilly unit plans to buy feed-enzyme maker

January 24, 2012
Associated Press
Drugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products that improve poultry, egg and meat production.
More

Walgreen marks retailers' push into health care

January 23, 2012
J.K. Wall
Health care reform is projected to cover 30 million more people with health insurance—and overwhelm the nation’s doctors. That's why retailers like Walgreen and Wal-Mart are moving into the space in a big way.
More

Poll: Anthem so-so in customer satisfaction

January 23, 2012
J.K. Wall
Anthem Blue Cross and Blue Shield ranked No. 12 in a new national customer satisfaction survey, but the poor showing doesn’t appear to threaten the Indianapolis-based company’s business success.<
More

Deal with Walgreen perplexes Arcadia's investorsRestricted Content

January 21, 2012
J.K. Wall
Something doesn’t add up about Arcadia Resources Inc.’s agreement to sell its pharmacy business for a low price of $2 million, according to many of the Indianapolis company’s investors.
More

Indiana deals ranged upward of $800 millionRestricted Content

January 21, 2012
Mergers and acquisitions in 2011 ranged from WellPoint's acquisition of CareMore to a trucking company merger.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Members must realize if you stop paying your dues you will lose. Why else would your employer honor the rtw bill. Before you take this step think about what you may be giving up in the long run. Very little of your dues money goes to any dem candidate. YOu will never know how much your republican employer gives his party with money he could be paying the employee. Who will step up and demand better wages or benefits if you have no representation. Union is the way for a better life. Our carpenter union offers a 4 year apprenticeship and 2 year degree from Ivy Tech all paid for with union dues . This is a great opportunity for kids who cant afford schooling after high school. The same opportunity is there for any person,any age, either sex to provide a better living for their family. Pension, anuity, health insurance all for your dues. How is this a bad choice.

  2. The FDIC is funded by assessments paid by banks, not taxpayers. That is not to say that bank customers don't ultimately pay the cost because, in the end, banks don't survive if they don't make profits.

  3. SCB Bank's failure is expected to cost the government $33.9 million,dont you mean middle class another bailout our government has no money

  4. Diogenes, the company did not call "pro-life" statements inflammatory. The IBJ article used the words "pro life."

    All, the company did, is what it should do which is apologize profusely for offending people with a program that offered statements that support an infamous apartheid proponent, Dr. Verwoerd, suggest that sometimes rape is justified, and quote Biblical text to people, not looking for it.

    If this is what you think is "insanity" then more companies need to behave insanely.

  5. I totally disagree with $45mil being given to the state Attorney General's office. That money is a waste. All of the money should go to help the homeowners & the people who were foreclosed on. Why such a big percentage to state govt? They'll get to start another agency staffed with people who have new-found power & don't care about the people they serve. As soon as the program was announced, I knew the states would end up with a huge chunk of the money for themselves that would just be squandered. Or maybe Mitch Daniels will just happen to "find" another big chunk of money that was "posted in the wrong section of the state's books."

ADVERTISEMENT